Abstract
Objective: To investigate a signal generated by an observational cohort study that treatment with the potassium channel opener drug, nicorandil, is associated with an increased incidence of diabetes mellitus (DM).
Methods: Nested case-control study within cohorts used for prescription-event monitoring.
Results: The cohort study of nicorandil showed that there was a significant difference between the event rate for DM in the first month after starting nicorandil, compared to months 2–6 (difference in rates 1.93, 99% CI 0.7–3.1, per 1000 patient months of treatment). However, the adjusted odds ratio from the case-control study was 1.42 (95% CI 0.66–3.07) for incidence of newly diagnosed DM in nicorandil versus four comparator drugs.
Conclusions: The nested case-control study was used as a hypothesis-testing instrument for following up a signal of a possible drug reaction to nicorandil. It showed no evidence that nicorandil is associated with increased incidence of newly diagnosed DM.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 12 January 1998 / Accepted in revised form: 12 August 1998
Rights and permissions
About this article
Cite this article
Dunn, N., Freemantle, S. & Mann, R. Nicorandil and diabetes: a nested case-control study to examine a signal generated by prescription-event monitoring. E J Clin Pharmacol 55, 159–162 (1999). https://doi.org/10.1007/s002280050612
Issue Date:
DOI: https://doi.org/10.1007/s002280050612